Superbugs


  • Comating MDROs
    In recent months, the medical community has witnessed outbreaks of NDM-1, KPC and a new strain of Escherichia coli, underscoring the urgency of addressing antibiotic stewardship to save lives and billions of dollars in costs caused by antibiotic-resistant and ...More
    July 18, 2011 Posted in Content Library
  • Scientists Develop Fatty 'Kryptonite' to Defeat Multidrug-Resistant Superbugs
    Superbugs, which can cause wide-spread disease and may be resistant to most, if not all, conventional antibiotics, still have their weaknesses. A team of Canadian scientists discovered that specific mixtures of antimicrobial agents presented in lipid (fatty) mixtures can ...More
    June 17, 2011 Posted in News
  • Life-Saving Antibiotics Face a Doubtful Future
    To head off a healthcare disaster, the Infectious Diseases Society of America (IDSA) has developed a plan to combat deadly antibiotic-resistant superbugs and is rolling out the multi-pronged plan today, on World Health Day 2011. Infections are becoming increasingly ...More
    April 7, 2011 Posted in News
  • Communication Pathways Within Proteins May Yield New Drug Targets to Stop Superbugs
    A School of Science at Indiana University-Purdue University Indianapolis biophysicist has developed a new method to identify communication pathways connecting distant regions within proteins. With this tool, Andrew J. Rader, PhD, assistant professor of physics, has ...More
    January 31, 2011 Posted in News
  • Identifying Enzymes to Explode Superbugs
    With the worrying rise of antibiotic-resistant superbugs like methicillin-resistant Staphylococcus aureus (MRSA), scientists from a wide range of disciplines are teaming up to identify alternative therapies to keep them at bay. One long-considered solution is the use of ...More
    October 4, 2010 Posted in News
  • Emerging Infectious Diseases Pose Current and Future Challenges
    Newly recognized disease-causing viruses, bacteria and other infections are continually emerging around the world, posing difficult challenges for patient diagnosis and treatment and for public health responses. A special symposium section of the September issue of the ...More
    September 22, 2010 Posted in News
  • Nearly 400 Medicines and Vaccines in Development to Fight Infectious Diseases
    Critical challenges remain in the centuries-old battles against infectious diseases, particularly as bacteria and viruses mutate and as the threat of bioterrorism grows. Responding to this need, America’s biopharmaceutical research companies this year have 395 new medicines ...More
    September 10, 2010 Posted in News
  • Poster Details High-Risk Areas for Hospital Superbugs
    EMLab P&K, a testing laboratory, in collaboration with strategic alliance partner Philders Group International Inc., a consulting firm for infectious diseases, announces it has created a professionally designed infection control poster, “Infection Control Risk ...More
    August 26, 2010 Posted in News
  • BioScience Laboratories Announces Testing Capabilities for NDM-1
    BioScience Laboratories has obtained seven clinical isolates of Carbapenem-Resistant (CR) Klebsiella pneumoniae and Escherichia coli. These organisms provide a strong model for predicting a product's efficacy against superbugs such as the New Delhi metallo-a-lactamase 1 ...More
    August 25, 2010 Posted in News
  • Infectious Disease Specialist Addresses Rise of the Superbugs
    People all over the world are getting sick and dying of an incurable plague. Hospitals are inundated. And there is no cure in sight. It sounds like the plot to a far-fetched futuristic sci-fi movie, right? The bad news is it’s not, according to Brad Spellberg, MD, associate ...More
    August 11, 2010 Posted in News